fashion -WSS

fashion

author：knowledge 2025-10-01 20:16:10 - browse：2

Adam's take main illustration — Molly Ferguson/STAT

The eye disease physician in charge of a committee that flagged a rare but severe side effect involving a newly approved drug from Apellis Pharmaceuticals has financial ties to a competing drugmaker. The conflict raises questions about his supervision of an emerging safety issue for patients and its impact on the financial health of Apellis.

Peter Kaiser, a retinal disease expert who runs the Cole Eye Institute at the Cleveland Clinic, failed to report consulting fees and stock ownership in Iveric Bio on a financial disclosure form maintained by the American Society of Retina Specialists, or ASRS. Iveric Bio is developing a treatment for geographic atrophy, a common, age-related cause of vision loss and the same indication for which the Apellis drug was approved.

The financial conflict, which was undisclosed until after Kaiser was contacted about it by STAT, is relevant because Kaiser also chairs a committee of the ASRS responsible for monitoring the safety of retina drugs and devices. On July 15, Kaiser’s committee sent a letter to member doctors, alerting them to reports of eye inflammation in people receiving injections of Syfovre, the treatment recently approved and launched by Apellis.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Eli Lilly CEO gives to Mike Pence presidential super PAC

Wikipedia

WSS

Study finds new variant for Parkinson’s in African populations

People with substance use disorder deserve online privacy

Senate bill would ban some hospital facility fees

Senate bill would ban some hospital facility fees

Why the drug industry's warnings on the IRA's impact fall short

Medicare explains how it will choose drugs for negotiation

Wikipedia

fashion

leisure time

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Why the quest to eradicate polio has stumbled

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The unintended consequences of overturning Roe v. Wade

How one medical school became remarkably diverse

2024 GOP presidential candidates spar over abortion in debate

Tori Bowie and the unacceptable rates of Black maternal death

Akili changes sales model for its ADHD video game treatment

Peter Hotez and the public health issue of online harassment

People with substance use disorder deserve online privacy

focus

In science, is the line between industry and academia shifting?

Assistant physicians can help address the primary care shortage

In science, is the line between industry and academia shifting?

Complete sequence of Y chromosome published for first time

The struggle to figure out which patients 'deserve' Wegovy

Chamber of Commerce, DOJ clash in court over drug prices

Wikipedia

leisure time

knowledge

focus